title: What to Do With the Participants/Patients in Phase III Clinical Cancer Trials That Have Been Stopped by the FDA.
authors.affiliation: Affiliations of author: Departments of Medicine, Biological Chemistry, Public Health, and Epidemiology and the Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA. Flmeyske@uci.edu.
authors.forename: Frank L
authors.initials: FL
authors.lastname: Meyskens
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009369:Neoplasms